Literature DB >> 10571515

Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.

H Sato1, T Hasegawa, Y Abe, H Sakai, S Hirohashi.   

Abstract

The cadherin-mediated cell-cell adhesion system is now known to play a critical role in both the morphogenesis of cancer cells and suppression of their invasion. However, the pattern of expression of E-cadherin, the major cadherin of epithelial cells in bone and soft tissue sarcomas, remains unclear. This prompted us to study E-cadherin expression in a variety of bone and soft tissue sarcomas. Using the monoclonal antibody HECD-1, raised against the extracellular domain of E-cadherin, we observed immunoreactivity in 1 pleomorphic rhabdomyosarcoma, 2 of 5 diffuse mesotheliomas, 4 of 5 clear cell sarcomas, 1 of 5 epithelioid sarcomas, and 10 synovial sarcomas. Other types of bone and soft tissue sarcoma (4 osteosarcomas, 4 chondrosarcomas, 3 primitive neuroectodermal tumors, 1 fibrosarcoma, 4 malignant fibrous histiocytomas, 5 liposarcomas, 4 leiomyosarcomas, 6 alveolar and 5 embryonal rhabdomyosarcomas, 4 angiosarcomas, 4 malignant peripheral nerve sheath tumors, 2 extraskeletal myxoid chondrosarcomas, 2 extraskeletal osteosarcomas, and 3 alveolar soft part sarcomas) were completely negative for E-cadherin. Our findings indicate that E-cadherin is expressed in certain kinds of soft tissue sarcomas, especially those with epithelioid features, suggesting that E-cadherin plays a role in the constitution of their architecture.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571515     DOI: 10.1016/s0046-8177(99)90066-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Biphasic solitary fibrous tumour: a report of two cases with epithelioid features.

Authors:  R Awasthi; J K O'Neill; C E Keen; P T L Sarsfield; V S Devaraj; C A Stone; M E F Smith
Journal:  Virchows Arch       Date:  2005-10-22       Impact factor: 4.064

2.  Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.

Authors:  Pinelopi N Gogou; Anna Batistatou; Emilios E Pakos; Nikiforos Apostolikas; Dimitrios Stefanou; Pericles G Tsekeris
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

3.  E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.

Authors:  Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A May; Tony Ng; C Patrick Reynolds; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

4.  Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug.

Authors:  Jilong Yang; James A Eddy; Yuan Pan; Andrea Hategan; Ioan Tabus; Yingmei Wang; David Cogdell; Nathan D Price; Raphael E Pollock; Alexander J F Lazar; Kelly K Hunt; Jonathan C Trent; Wei Zhang
Journal:  Mol Cell Proteomics       Date:  2010-07-22       Impact factor: 5.911

Review 5.  Research models and mesenchymal/epithelial plasticity of osteosarcoma.

Authors:  Xiaobin Yu; Jason T Yustein; Jianming Xu
Journal:  Cell Biosci       Date:  2021-05-22       Impact factor: 7.133

6.  Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.

Authors:  Pinelopi Gogou; Emilios Pakos; Anna Batistatou; Ioannis Panelos; Evangelos Briasoulis; Dimitrios Stefanou; Nikoforos Apostolikas; Periclis Tsekeris
Journal:  World J Surg Oncol       Date:  2012-02-02       Impact factor: 2.754

7.  Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.

Authors:  Ning Wang; Yong-Lai He; Li-Juan Pang; Hong Zou; Chun-Xia Liu; Jin Zhao; Jian-Ming Hu; Wen-Jie Zhang; Yan Qi; Feng Li
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 8.  EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.

Authors:  Ulf D Kahlert; Justin V Joseph; Frank A E Kruyt
Journal:  Mol Oncol       Date:  2017-06-19       Impact factor: 6.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.